MITF |
|||
CSB-CL014595HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
MITF |
|||
GWB-9E1C13 | GenWay Biotech | 0.01 mg | Ask for price |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC810915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF680R conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC810915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF680R conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC800915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF680 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC800915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF680 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC430915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF543 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC430915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF543 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC050915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF405M conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC050915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF405M conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC550915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF555 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC550915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF555 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC700915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF770 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC700915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF770 conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC610915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF660R conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNC610915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), CF660R conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCP0915-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), PerCP conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCR0915-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), RPE conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCA0915-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), APC conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCAP0915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCAP0915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCH0915-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MiTF (Microphthalmia Transcription Factor)(MITF/915) Antibody |
|||
BNCH0915-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MiTF (Microphthalmia Transcription Factor)(MITF/915), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Microphthalmia Transcription Factor (MITF)(MITF/2987R), 1mg/mL |
|||
BNUM2987-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Microphthalmia Transcription Factor (MITF)(MITF/2987R), 0.2mg/mL |
|||
BNUB2987-100 | Biotium | 1uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Microphthalmia Transcription Factor (MITF)(MITF/2987R), 0.2mg/mL |
|||
BNUB2987-500 | Biotium | 1uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MITF siRNA |
|||
20-abx924199 | Abbexa |
|
|
MITF siRNA |
|||
20-abx924200 | Abbexa |
|
|
MiTF (Microphthalmia Transcription Factor)(MITF/915), 0.2mg/mL |
|||
BNUB0915-100 | Biotium | 100uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MiTF (Microphthalmia Transcription Factor)(MITF/915), 0.2mg/mL |
|||
BNUB0915-500 | Biotium | 500uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MiTF (Microphthalmia Transcription Factor)(MITF/915), 1mg/mL |
|||
BNUM0915-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MITF Antibody |
|||
ABD6384 | Lifescience Market | 100 ug | EUR 525.6 |
MITF Antibody |
|||
32260 | SAB | 100ul | EUR 439 |
MITF Antibody |
|||
32260-100ul | SAB | 100ul | EUR 302.4 |
MiTF Antibody |
|||
49400 | SAB | 100ul | EUR 499 |
MiTF Antibody |
|||
49400-100ul | SAB | 100ul | EUR 399.6 |
MiTF Antibody |
|||
49400-50ul | SAB | 50ul | EUR 286.8 |
MITF Antibody |
|||
1-CSB-PA783063 | Cusabio |
|
|
Description: A polyclonal antibody against MITF. Recognizes MITF from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:5000, WB:1:500-1:2000 |
MITF Antibody |
|||
E10-31088 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
MITF Antibody |
|||
E10-31132 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
MITF Antibody |
|||
E18-6027-1 | EnoGene | 50μg/50μl | EUR 145 |
Description: Available in various conjugation types. |
MITF Antibody |
|||
E18-6027-2 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
MITF Antibody |
|||
1-CSB-PA014595GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against MITF. Recognizes MITF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
MITF Antibody |
|||
DF6384 | Affbiotech | 200ul | EUR 420 |
MITF Antibody |
|||
DF6384-100ul | Affinity Biosciences | 100ul | EUR 280 |
MITF Antibody |
|||
DF6384-200ul | Affinity Biosciences | 200ul | EUR 350 |
MITF Antibody |
|||
E91255 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
MITF Antibody |
|||
E311333 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
MITF antibody |
|||
70R-18523 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal MITF antibody |
MITF antibody |
|||
70R-35304 | Fitzgerald | 100 ug | EUR 294 |
Description: Purified Rabbit polyclonal MITF antibody |
MITF Antibody |
|||
AF6027 | Affbiotech | 200ul | EUR 420 |
MITF Antibody |
|||
AF6027-100ul | Affinity Biosciences | 100ul | EUR 280 |
MITF Antibody |
|||
AF6027-200ul | Affinity Biosciences | 200ul | EUR 350 |
MITF Antibody |
|||
AF7640 | Affbiotech | 200ul | EUR 540 |
MITF Antibody |
|||
AF7640-100ul | Affinity Biosciences | 100ul | EUR 350 |
MITF Antibody |
|||
AF7640-200ul | Affinity Biosciences | 200ul | EUR 450 |
MITF Antibody |
|||
AF7640-50ul | Affinity Biosciences | 50ul | EUR 250 |
MITF Antibody |
|||
AF7641 | Affbiotech | 200ul | EUR 540 |
MITF Antibody |
|||
AF7641-100ul | Affinity Biosciences | 100ul | EUR 350 |
MITF Antibody |
|||
AF7641-200ul | Affinity Biosciences | 200ul | EUR 450 |
MITF Antibody |
|||
AF7641-50ul | Affinity Biosciences | 50ul | EUR 250 |
MITF Antibody |
|||
1-CSB-PA003243 | Cusabio |
|
|
Description: A polyclonal antibody against MITF. Recognizes MITF from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000 |
MITF Antibody |
|||
ABF6027 | Lifescience Market | 100 ug | EUR 525.6 |
MITF Antibody |
|||
1-CSB-PA173368 | Cusabio |
|
|
Description: A polyclonal antibody against MITF. Recognizes MITF from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
MITF, Antibody |
|||
GWB-36C5AD | GenWay Biotech | 7 ml | Ask for price |
MiTF Antibody |
|||
GWB-F98685 | GenWay Biotech | 0.05 mg | Ask for price |
MITF, Antibody |
|||
GWB-B902BB | GenWay Biotech | 1 ml | Ask for price |
MITF Antibody |
|||
GWB-MM640A | GenWay Biotech | 50ug | Ask for price |
MITF Antibody |
|||
GWB-D96E18 | GenWay Biotech | 0.1 mg | Ask for price |
MITF Antibody |
|||
F41536-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: This gene encodes a transcription factor that contains both basic helix-loop-helix and leucine zipper structural features. It regulates the differentiation and development of melanocytes retinal pigment epithelium and is also responsible for pigment cell-specific transcription of the melanogenesis enzyme genes. Heterozygous mutations in the this gene cause auditory-pigmentary syndromes, such as Waardenburg syndrome type 2 and Tietz syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. |
MITF Antibody |
|||
F41536-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: This gene encodes a transcription factor that contains both basic helix-loop-helix and leucine zipper structural features. It regulates the differentiation and development of melanocytes retinal pigment epithelium and is also responsible for pigment cell-specific transcription of the melanogenesis enzyme genes. Heterozygous mutations in the this gene cause auditory-pigmentary syndromes, such as Waardenburg syndrome type 2 and Tietz syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. |
MITF Antibody |
|||
RQ4770 | NSJ Bioreagents | 100ul | EUR 356.15 |
Description: 'Microphthalmia-associated transcription factor' (MiTF) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. [UniProt] |
MITF Antibody |
|||
V8800-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: MITF (microphthalmia-associated transcription factor) is a melanocytic nuclear protein that contains basic helix-loop-helix (HLH) and leucine zipper (LZ) domains. These protein motifs are frequently observed in other transcription factors and are particularly common to members of the Myc family. MITF can directly associate with DNA as a homodimer and is required for the development and differentiation of melanocytes. Its expression is upregulated by cAMP and cAMP-dependent pathways. MITF activates several different gene promoters by binding to their E-boxes. Tyrosinase, TRP1 and TRP2 are pigment synthesis genes activated by MITF. When MITF is phosphorylated on Ser73 (via the MAPK pathway), it associates with co-activators of the p300/CBP family and enhances transcription. MITF has several isoforms including MITF-M which is specifically expressed in melanocytes. In MITFdeficient mice there is a complete absence of melanocytes. |
MITF Antibody |
|||
V8800-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: MITF (microphthalmia-associated transcription factor) is a melanocytic nuclear protein that contains basic helix-loop-helix (HLH) and leucine zipper (LZ) domains. These protein motifs are frequently observed in other transcription factors and are particularly common to members of the Myc family. MITF can directly associate with DNA as a homodimer and is required for the development and differentiation of melanocytes. Its expression is upregulated by cAMP and cAMP-dependent pathways. MITF activates several different gene promoters by binding to their E-boxes. Tyrosinase, TRP1 and TRP2 are pigment synthesis genes activated by MITF. When MITF is phosphorylated on Ser73 (via the MAPK pathway), it associates with co-activators of the p300/CBP family and enhances transcription. MITF has several isoforms including MITF-M which is specifically expressed in melanocytes. In MITFdeficient mice there is a complete absence of melanocytes. |
MITF Antibody |
|||
V8800SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: MITF (microphthalmia-associated transcription factor) is a melanocytic nuclear protein that contains basic helix-loop-helix (HLH) and leucine zipper (LZ) domains. These protein motifs are frequently observed in other transcription factors and are particularly common to members of the Myc family. MITF can directly associate with DNA as a homodimer and is required for the development and differentiation of melanocytes. Its expression is upregulated by cAMP and cAMP-dependent pathways. MITF activates several different gene promoters by binding to their E-boxes. Tyrosinase, TRP1 and TRP2 are pigment synthesis genes activated by MITF. When MITF is phosphorylated on Ser73 (via the MAPK pathway), it associates with co-activators of the p300/CBP family and enhances transcription. MITF has several isoforms including MITF-M which is specifically expressed in melanocytes. In MITFdeficient mice there is a complete absence of melanocytes. |
MITF Antibody |
|||
V7109-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7109-20UG | NSJ Bioreagents | 20 ug | EUR 186.15 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7109IHC-7ML | NSJ Bioreagents | 7 ml | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7109SAF-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7455-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7455-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7455IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7455SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: MITF (microphthalmia transcription factor) is a transcription factor that regulates the expression of genes with essential roles in cell differentiation, proliferation and survival. Binds to symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoters of target genes, such as BCL2 and tyrosinase (TYR). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. [UniProt] |
MITF Antibody |
|||
V7509-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. This mAb recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V7509-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. This mAb recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V7509IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. This mAb recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V7509SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. This mAb recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V2712-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. Anti-MITF, D5, recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V2712-20UG | NSJ Bioreagents | 20 ug | EUR 186.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. Anti-MITF, D5, recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V2712IHC-7ML | NSJ Bioreagents | 7 ml | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. Anti-MITF, D5, recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V2712SAF-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. Anti-MITF, D5, recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. |
MITF Antibody |
|||
V2713-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, -B, -C, -H, and -M, which differ in the amino-terminal domain and in their expression patterns. The M isoform is restricted to the melanocyte cell lineage. |
MITF Antibody |
|||
V2713-20UG | NSJ Bioreagents | 20 ug | EUR 186.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, -B, -C, -H, and -M, which differ in the amino-terminal domain and in their expression patterns. The M isoform is restricted to the melanocyte cell lineage. |
MITF Antibody |
|||
V2713IHC-7ML | NSJ Bioreagents | 7 ml | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, -B, -C, -H, and -M, which differ in the amino-terminal domain and in their expression patterns. The M isoform is restricted to the melanocyte cell lineage. |
MITF Antibody |
|||
V2713SAF-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, -B, -C, -H, and -M, which differ in the amino-terminal domain and in their expression patterns. The M isoform is restricted to the melanocyte cell lineage. |